Breaking News Instant updates and real-time market news.

AGN

Allergan

$230.54

-7.41 (-3.11%)

07:09
10/13/16
10/13
07:09
10/13/16
07:09

Allergan's Belkyra receives marketing authorization in Sweden

Allergan announced that Sweden has received the Marketing Authorisation for Belkyra after being granted approval by the Swedish Medical Products Agency. Belkyra is a prescription medicine for the treatment of moderate-to-severe convexity or fullness associated with submental fat or double chin in adults when the presence of submental fat has a psychological impact for the patient.

  • 06

    Nov

AGN Allergan
$230.54

-7.41 (-3.11%)

09/21/16
CANT
09/21/16
DOWNGRADE
CANT
Hold
Tobira Therapeutics downgraded to Hold from Buy at Cantor
Cantor analyst Elemer Piros downgraded Tobira (TBRA) after the company agreed to be acquired by Allergan (AGN). Target to $42 from $19.
09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

CBI

CB&I

$32.06

-1.7901 (-5.29%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$28.99

0.465 (1.63%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Conference/Events
MGM Resorts participates in a luncheon meeting hosted by the National Press Club »

James Murren, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

VASC

Vascular Solutions

12:48
12/02/16
12/02
12:48
12/02/16
12:48
Downgrade
Vascular Solutions rating change  »

Vascular Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/02/16
12/02
12:45
12/02/16
12:45
General news
Breaking General news story  »

Week of 12/2 Baker-Hughes…

NUS

Nu Skin

$50.75

0.52 (1.04%)

12:44
12/02/16
12/02
12:44
12/02/16
12:44
Conference/Events
Nu Skin to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

, IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

12:41
12/02/16
12/02
12:41
12/02/16
12:41
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week total flows…

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

XOP

SPDR Oil Exploration and Production Fund

$41.98

-0.075 (-0.18%)

FXR

First Trust Industrials/Producer Durables AlphaDEX Fund

$33.03

0.0144 (0.04%)

GLD

SPDR Gold Trust

$112.20

0.6635 (0.59%)

IAU

iShares Gold Trust

$11.34

0.07 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

12:40
12/02/16
12/02
12:40
12/02/16
12:40
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

, JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

12:34
12/02/16
12/02
12:34
12/02/16
12:34
Periodicals
Actelion's silence speaks volumes to hedge funds, Reuters says »

Actelion's (ALIOF)…

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.51

0.0018 (0.35%)

, BSX

Boston Scientific

$20.33

0.235 (1.17%)

12:31
12/02/16
12/02
12:31
12/02/16
12:31
Recommendations
Neovasc, Boston Scientific analyst commentary  »

Neovasc's Boston…

NVCN

Neovasc

$0.51

0.0018 (0.35%)

BSX

Boston Scientific

$20.33

0.235 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

FE

FirstEnergy

$30.62

-0.37 (-1.19%)

12:30
12/02/16
12/02
12:30
12/02/16
12:30
Options
Flurry of activity in First Energy puts »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

IBERIABANK

$84.15

1.3 (1.57%)

12:26
12/02/16
12/02
12:26
12/02/16
12:26
Upgrade
IBERIABANK rating change  »

IBERIABANK upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

12:20
12/02/16
12/02
12:20
12/02/16
12:20
General news
Treasury Option Action: and now some bullish call buying »

Treasury Option Action:…

PBIB

Porter Bancorp

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp says court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
12/02/16
12/02
12:15
12/02/16
12:15
General news
Breaking General news story  »

Federal Reserve Gov.…

PBIB

Porter Bancorp

12:13
12/02/16
12/02
12:13
12/02/16
12:13
Hot Stocks
Porter Bancorp announces appellate court affirms ruling »

Porter Bancorp, parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$58.51

0.54 (0.93%)

, WDAY

Workday

$71.33

-10.275 (-12.59%)

12:12
12/02/16
12/02
12:12
12/02/16
12:12
General news
On The Fly: Top stock stories at midday »

Stocks opened with modest…

SBUX

Starbucks

$58.51

0.54 (0.93%)

WDAY

Workday

$71.33

-10.275 (-12.59%)

ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

P

Pandora

$12.58

1.095 (9.54%)

SIRI

Sirius XM

$4.56

-0.015 (-0.33%)

BX

Blackstone

$25.82

-0.33 (-1.26%)

GM

General Motors

$35.75

-0.6802 (-1.87%)

JPM

JPMorgan

$81.22

-0.57 (-0.70%)

BLK

BlackRock

$372.34

-4.86 (-1.29%)

DIS

Disney

$98.47

-0.4661 (-0.47%)

WMT

Wal-Mart

$70.74

0.0662 (0.09%)

IBM

IBM

$159.48

-0.342 (-0.21%)

INFO

IHS Markit

$35.11

-0.83 (-2.31%)

ASNA

Ascena Retail

$5.83

-0.21 (-3.48%)

FIVE

Five Below

$39.88

0.52 (1.32%)

AMBA

Ambarella

$61.39

-0.13 (-0.21%)

SWHC

Smith & Wesson

$23.98

0.65 (2.79%)

ATI

Allegheny Technologies

$16.05

-1.71 (-9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

SOHO

Sotherly Hotels

$5.48

-0.01 (-0.18%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Hot Stocks
Sotherly Hotels announces $10M stock repurchase program »

Sotherly Hotels announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$7.65

-0.09 (-1.16%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Options
Fiat Chrysler Dec 7 - 8 call spread at 64c, 4K on ISE »

Fiat Chrysler Dec 7 - 8…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

PBIB

Porter Bancorp

12:07
12/02/16
12/02
12:07
12/02/16
12:07
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.80

-0.26 (-1.62%)

12:02
12/02/16
12/02
12:02
12/02/16
12:02
Periodicals
Deutsche Bank to cease some coverage for about 3,400 clients, WSJ says »

Deutsche Bank plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

OZM

Och-Ziff Capital

$3.14

0.18 (6.08%)

12:01
12/02/16
12/02
12:01
12/02/16
12:01
Hot Stocks
Och-Ziff Capital advances after AUM increased in November »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$11.93

-0.47 (-3.79%)

12:00
12/02/16
12/02
12:00
12/02/16
12:00
Options
Third day of interest in Etsy Mar 15 calls »

Third day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TEVA

Teva

$36.76

0.19 (0.52%)

11:53
12/02/16
12/02
11:53
12/02/16
11:53
Options
Sweep buyer of short dated TEVA Calls »

Sweep buyer of short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.